CRCbioscreen

Cancer screening revolution

This company develops non-invasive stool-based DNA tests for the detection of colorectal cancer in adults aged forty-five and older.

CanSense

This company develops blood-based diagnostic tests using laser spectroscopy and artificial intelligence for early-stage bowel cancer detection for healthcare providers and laboratories.

GoodGut

This company develops non-invasive faecal diagnostic tests and prebiotic supplements for healthcare professionals and patients to identify and treat digestive diseases.

Geneoscopy

The company develops non-invasive, stool-based RNA diagnostic tests for colorectal cancer screening and gastrointestinal disease monitoring for patients and healthcare providers.

NostraBiome

This company provides microbiome testing kits and AI-driven health reports for patients and doctors to manage chronic conditions like digestive disorders and cancer.

Digistain

This company develops a diagnostic test using infrared spectroscopy to provide breast cancer recurrence-risk stratification for oncologists and multidisciplinary clinical teams.

Dxcover

This company develops an artificial intelligence platform and liquid biopsy blood tests for healthcare providers to achieve earlier cancer detection.

Amadix

This company develops blood-based liquid biopsy tests for the early detection of colorectal, lung and pancreatic cancer in patients and healthcare settings.